Short-Term Efficacy and Safety of Oral Selective Orexin-2 Receptor Agonists in Narcolepsy Type 1: An Updated Systematic Review and Meta-Analysis of Randomized Trials.
Neuropsychopharmacology reports · 2026
Abstract e pubblicazione originale
L’abstract è consultabile nella fonte originale. Non viene ripubblicato qui perché non risulta verificata una licenza compatibile.
Leggi nella fonte originale ↗Parole chiave
HumansNarcolepsyRandomized Controlled Trials as TopicOrexin ReceptorsAdministration, OralTreatment Outcomealixorextoncataplexynarcolepsy Type 1orexin‐2 receptor agonistsoveporexton
Come citare questo studio
Aasim Ali, Ali Sajjad, Muhammad Talha, Khadija Waqar, Anousha Tanveer, Ammara Mehmood, Abdul Wahab, Muhammad Ahmad Shahid, Obaid Ur Rehman Rana, Armaghana Abdullah, Mukesh Kumar Sharma. (2026). Short-Term Efficacy and Safety of Oral Selective Orexin-2 Receptor Agonists in Narcolepsy Type 1: An Updated Systematic Review and Meta-Analysis of Randomized Trials.. Neuropsychopharmacology reports. DOI: 10.1002/npr2.70189
Consulta la pubblicazione originale ↗